Here's what 'SPOOKED' the market this week

Market Overview - The market experienced volatility due to a mix of predictions about AI's impact on the economy and actual layoffs attributed to AI [2][3] - A report on wholesale inflation showed a higher-than-expected increase of 0.5%, contributing to market concerns [4][5] - The Producer Price Index (PPI) has indicated a trend of rising wholesale inflation, which could affect consumer prices in the long term [6] Federal Reserve Outlook - Expectations for significant rate cuts in the upcoming March meeting have diminished due to persistent inflation data [7] - The incoming Fed chair, Kevin Worsh, faces challenges in convincing a hawkish panel regarding rate adjustments [8] Employment and Retail Sector - The upcoming jobs report is anticipated to be crucial, with estimates suggesting a decrease in payroll growth to about 65,000 for February [9] - Retail earnings from major companies like Costco and Target are also expected, which will provide insights into consumer spending trends [10] Software Industry Insights - Concerns about AI disrupting the software industry have led to a mixed performance, with the main software index down 20% for the year despite a recent 2% uptick [11][12] - Earnings reports from companies like Salesforce showed positive results, while others like Zscaler and Snowflake faced declines [12] Healthcare Sector Developments - In the GLP-1 drug market, Eli Lilly's Zepbound outperformed Novo Nordisk's drug in a head-to-head trial, leading to a decline in Novo's stock [16][17] - Novo's stock has dropped significantly, trading under 15 times earnings, while Eli Lilly trades at 30 times earnings, indicating a valuation disparity [18][19]